CONTROL OF HEART MITOCHONDRIAL NADH BY WORK AND CA++

Information

  • Research Project
  • 6460205
  • ApplicationId
    6460205
  • Core Project Number
    R29HL057562
  • Full Project Number
    7R29HL057562-06
  • Serial Number
    57562
  • FOA Number
  • Sub Project Id
  • Project Start Date
    1/1/1997 - 27 years ago
  • Project End Date
    12/31/2002 - 21 years ago
  • Program Officer Name
    LIANG, ISABELLA Y
  • Budget Start Date
    5/1/2001 - 23 years ago
  • Budget End Date
    12/31/2002 - 21 years ago
  • Fiscal Year
    2001
  • Support Year
    6
  • Suffix
  • Award Notice Date
    7/20/2001 - 22 years ago

CONTROL OF HEART MITOCHONDRIAL NADH BY WORK AND CA++

DESCRIPTION (adapted from the applicant's abstract): With increased cardiac work, the production of energy is precisely matched to meet the new demand. Mechanisms to explain this have included ADP, ATP, Pi or NADHm as control signals. Recent attention has been focused on NADHm since increased [NADH]m may increase energy production. However, it is unclear whether and how increased work is coupled to increased [NADH]m. The central hypothesis is that increased work causes increased cytosolic and subsequently mitochondrial [Ca2+] ([Ca2+]c and [Ca2+]m), which stimulates dehydrogenases to increase NADHm production and [NADH]m. Focal questions are: Does increased work cause increased [NADH]m? 1. Does increased [Ca2+]c or [Ca2+]m cause increased [NADH]m? 2. Is PDH the control site for increasing [NADH]m? 3. Does [NADH]m control the oxidative phosphorylation rate? Rat trabeculae will be isolated, and work, [NADH]m, [Ca2+]c, [Ca2+]m and oxygen consumption will be measured. Work will be altered by protocols that either increase [Ca2+]c (altering pacing rate and [Ca2+]o) or do not (altering sarcomere length). From this, it may be determined whether or not increased work causes increased [NADH]m, as well as the possible influence of [Ca2+]c. This will be further investigated by directly determining the relationships between work & [Ca2+]c, [Ca2+]c & [Ca2+]m and [Ca2+]m & [NADH]m. From these studies it may be concluded whether increased [NADH]m is, indeed, caused by increased [Ca2+]m during increased work. To determine if PDH is a key regulatory enzyme, substrate will be altered to either bypass PDH or not. If increased [NADH]m increases oxygen consumption rate, it will be concluded that [NADH]m controls oxidative phosphorylation. It is possible that the regulatory mechanisms also depend on the energy state of the heart, so work regime, temperature and redox and phosphorylation potentials (by altering substrate) will be varied.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R29
  • Administering IC
    HL
  • Application Type
    7
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    77251
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:77251\
  • Funding Mechanism
  • Study Section
    CVA
  • Study Section Name
    Cardiovascular Study Section
  • Organization Name
    NOVASITE PHARMACEUTICALS, INC.
  • Organization Department
  • Organization DUNS
    113386366
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    92121
  • Organization District
    UNITED STATES